Survivin, a human inhibitor of apoptosis protein (IAP), plays an important role in both cell cycle regulation and inhibition of apoptosis. Survivin is expressed in cells during the G(2)/M phase of the cell cycle, followed by rapid decline of both mRNA and protein levels at the G(1) phase. It has been suggested that cell cycle-dependent expression of survivin is regulated at the transcriptional level. In this study we demonstrate involvement of the ubiquitin-proteasome pathway in post-translational regulation of survivin. Survivin is a short-lived protein with a half-life of about 30 minutes and proteasome inhibitors greatly stabilise survivin in vivo. Expression of the survivin gene under the control of the CMV promoter cannot block cell cycle-dependent degradation of the protein. Proteasome inhibitors can block survivin degradation during the G(1) phase and polyubiquitinated derivatives can be detected in vivo. Mutation of critical amino acid residues within the baculovirus IAP repeat (BIR) domain or truncation of the N terminus or the C terminus sensitises survivin to proteasome degradation. Together, these results indicate that the ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner and structural changes greatly destabilise the survivin protein.
REFERENCES
Aberle
H.
, Bauer
A.
, Stappert
J.
, Kispert
A.
, Kemler
R.
(1997
). Beta-catenin is a target for the ubiquitin-proteasome pathway.
EMBO J
16
, 3797
–3804
Chen
Z. J.
, Parent
L.
, Maniatis
T.
(1996
). Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.
Cell
84
, 853
–862
Ciechanover
A.
(1998
). The ubiquitin-proteasome pathway: on protein death and cell life.
EMBO J
17
, 7151
–7160
Deveraux
Q. L.
, Reed
J. C.
(1999
). IAP family proteins—suppressors of apoptosis.
Genes Dev
13
, 239
–252
Deveraux
Q. L.
, Roy
N.
, Stennicke
H. R.
, Van Arsdale
T.
, Zhou
Q.
, Srinivasula
S. M.
, Alnemri
E. S.
, Salvesen
G. S.
, Reed
J. C.
(1998
). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.
EMBO J
17
, 2215
–2223
Deveraux
Q. L.
, Takahashi
R.
, Salvesen
G. S.
, Reed
J. C.
(1997
). X-linked IAP is a direct inhibitor of cell-death proteases.
Nature
388
, 300
–304
Fenteany
G.
, Standaert
R. F.
, Lane
W. S.
, Choi
S.
, Corey
E. J.
, Schreiber
S. L.
(1995
). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Science
268
, 726
–731
Fraser
A. G.
, James
C.
, Evan
G. I.
, Hengartner
M. O.
(1999
). Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis.
Curr. Biol
9
, 292
–301
Grossman
D.
, McNiff
J. M.
, Li
F.
, Altieri
D. C.
(1999
). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
J. Invest. Dermatol
113
, 1076
–1081
Grossman
D.
, McNiff
J. M.
, Li
F.
, Altieri
D. C.
(1999
). Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
Lab. Invest
79
, 1121
–1126
Hateboer
G.
, Kerkhoven
R. M.
, Shvarts
A.
, Bernards
R.
, Beijersbergen
R. L.
(1996
). Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
Genes Dev
10
, 2960
–2970
Janknecht
R.
, de Martynoff
G.
, Lou
J.
, Hipskind
R. A.
, Nordheim
A.
, Stunnenberg
H. G.
(1991
). Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.
Proc. Natl. Acad. Sci. USA
88
, 8972
–8976
Kawasaki
H.
, Altieri
D. C.
, Lu
C. D.
, Toyoda
M.
, Tenjo
T.
, Tanigawa
N.
(1998
). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Cancer Res
58
, 5071
–5074
King
R. W.
, Deshaies
R. J.
, Peters
J. M.
, Kirschner
M. W.
(1996
). How proteolysis drives the cell cycle.
Science
274
, 1652
–1659
Kobayashi
K.
, Hatano
M.
, Otaki
M.
, Ogasawara
T.
, Tokuhisa
T.
(1999
). Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation.
Proc. Natl. Acad. Sci. USA
96
, 1457
–1462
Koepp
D. M.
, Harper
J. W.
, Elledge
S. J.
(1999
). How the cyclin became a cyclin: regulated proteolysis in the cell cycle.
Cell
97
, 431
–434
LaCasse
E. C.
, Baird
S.
, Korneluk
R. G.
, MacKenzie
A. E.
) (1998
). The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
Oncogene
17
, 3247
–3259
Laney
J. D.
, Hochstrasser
M.
(1999
). Substrate targeting in the ubiquitin system.
Cell
97
, 427
–430
Li
F.
, Ambrosini
G.
, Chu
E. Y.
, Plescia
J.
, Tognin
S.
, Marchisio
P. C.
, Altieri
D. C.
(1998
). Control of apoptosis and mitotic spindle checkpoint by survivin.
Nature
396
, 580
–584
Lu
C. D.
, Altieri
D. C.
, Tanigawa
N.
(1998
). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.
Cancer Res
58
, 1808
–1812
Orford
K.
, Crockett
C.
, Jensen
J. P.
, Weissman
A. M.
, Byers
S. W.
(1997
). Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin.
J. Biol. Chem
272
, 24735
–24738
Patrick
G. N.
, Zhou
P.
, Kwon
Y. T.
, Howley
P. M.
, Tsai
L. H.
(1998
). p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
J. Biol. Chem
273
, 24057
–24064
Roy
N.
, Deveraux
Q. L.
, Takahashi
R.
, Salvesen
G. S.
, Reed
J. C.
(1997
). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.
EMBO J
16
, 6914
–6925
Scheffner
M.
, Werness
B. A.
, Huibregtse
J. M.
, Levine
A. J.
, Howley
P. M.
(1990
). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
Cell
63
, 1129
–1136
Shirane
M.
, Harumiya
Y.
, Ishida
N.
, Hirai
A.
, Miyamoto
C.
, Hatakeyama
S.
, Nakayama
K.
, Kitagawa
M.
(1999
). Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.
J. Biol. Chem
274
, 13886
–13893
Sun
C.
, Cai
M.
, Gunasekera
A. H.
, Meadows
R. P.
, Wang
H.
, Chen
J.
, Zhang
H.
, Wu
W.
, Xu
N.
, Ng
S. C.
, Fesik
S. W.
(1999
). NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
Nature
401
, 818
–822
Takahashi
R.
, Deveraux
Q.
, Tamm
I.
, Welsh
K.
, Assa-Munt
N.
, Salvesen
G. S.
, Reed
J. C.
(1998
). A single BIR domain of XIAP sufficient for inhibiting caspases.
J Biol Chem
273
, 7787
–7790
Tamm
I.
, Wang
Y.
, Sausville
E.
, Scudiero
D. A.
, Vigna
N.
, Oltersdorf
T.
, Reed
J. C.
(1998
). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs.
Cancer Res
58
, 5315
–5320
Tenev
T.
, Bohmer
S. A.
, Kaufmann
R.
, Frese
S.
, Bittorf
T.
, Beckers
T.
, Bohmer
F. D.
(2000
). Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells.
Eur. J. Cell Biol
79
, 261
–271
Treier
M.
, Staszewski
L. M.
, Bohmann
D.
(1994
). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.
Cell
78
, 787
–798
Uren
A. G.
, Beilharz
T.
, O'Connell
M. J.
, Bugg
S. J.
, van Driel
R.
, Vaux
D. L.
, Lithgow
T.
(1999
). Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division.
Proc. Natl. Acad. Sci. USA
96
, 10170
–10175
Ward
C. L.
, Omura
S.
, Kopito
R. R.
(1995
). Degradation of CFTR by the ubiquitin-proteasome pathway.
Cell
83
, 121
–127
Zhu
H.
, Kavsak
P.
, Abdollah
S.
, Wrana
J. L.
, Thomsen
G. H.
(1999
). A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
Nature
400
, 687
–693
This content is only available via PDF.
© 2000 by Company of Biologists
2000
-PolarityCFP.png?versionId=4696)
